SMNR

AS OF

Jan 13 closing price

Price

$8.80

Change

-$0.00 (-0.00%)

Capitalization

2.02B

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

SMNR

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Semnur Pharmaceuticals (SMNR) Ownership - Who owns Semnur Pharmaceuticals?

Semnur Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Fundamentals

SMNR

Capitalization

2.02B

P/E Ratio

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

85K

Total Cash/Share

0.00

Total Debt

9.81M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

-14.59M

P/B Ratio

N/A

Cash Flow

N/A

Earnings

-0.67

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

23K

Current Ratio

0.01

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-155.03M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-20030.23

Shares Held By Institutions

N/A

Shares Outstanding - Current

230M

Total Liabilities

15.4M

Total Volume MTD

N/A

Value

Gain YTD

-61.739

View a ticker or compare two or three

Compare

SMNR

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.

View AI-Driven Trading for SMNR

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details